Hanzema · DIN 02477432 · 10 mg · capsule
Limited Use, Reason for Use code 442 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 442 required
Write on scriptReason for Use code 442 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 442
Reason for Use code 442
For adult patients with severe (see note 1 below) chronic (see note 2 below) hand eczema AND unresponsive to an 8 week course of high potency topical corticosteroids.
1. Severe defined based on the Physician Global Assessment (PGA), including:
- At least one of the following cardinal features present at baseline as moderate or severe: erythema, scaling, hyperkeratosis/lichenification; and
- one of the following features present as severe: vesiculation, edema, fissures, pruritus/pain; and
- with an area of greater than 30% of affected hand surface
2. Chronic defined as:
- persists for greater than 3 months; OR
- reoccurs greater than or equal to 2 times within 12 months
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Hanzema · DIN 02477432
Manufacturer: Dr. Reddy's Laboratories Inc.; listing date 2021-07-30
Health Canada: Marketed since 2021-06-09 · brand HANZEMA · ATC D11AH04 ALITRETINOIN · form Capsule · route Oral · ingredients ALITRETINOIN 10 MG · company Dr. reddy's laboratories inc · schedule Prescription
Hanzema: Formulary list price $16.99 per unit (the source does not state the unit; exact figure $16.9868). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02477432)
Source record
DIN 02477432: Hanzema
Raw flags: sec12=Y, sec3=Y
Item: 843600092; group id 856; item number 2076; lccId 00234; manufacturer id DRR
Source form: Cap; strength: 10mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $16.9868; ministry $16.9868
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02477432
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96841
Interchangeable products
Toctino · DIN 02337630 · not recorded
Shortage status: not checked (no credentials)